11q23/lysine methyltransferase 2A (KMT2A) rearrangements represent recurrent cytogenetic aberrations in AML, often detected in pediatric AML and associated with high CD33 expression on leukemic blasts [71]. Here, KMT2A is linked to acute myeloid leukemia.